CRH Medical renews normal course issuer bid — 3 insights

The Toronto Stock Exchange approved CRH Medical’s intention to renew its normal course issuer bid.

Advertisement

Here’s what you should know:

1. CRH may purchase up to 7 million of its common shares, representing 9.74 percent of its outstanding common shares.

2. CRH currently has 72.3 million in common shares and a public float of 70.44 million.

3. CRH will fund the bid with generated cash flow.

More articles on healthcare: 
3 thoughts on managing denials from employer plans
GI societies slam CMS decision to side with Anthem, devalue GI codes — 5 insights
USPI delivers $502M operating revenue in Q3, Tenet’s hospital operations disappoint

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

  • Premier Health Partners has acquired Dayton, Ohio-based Digestive Specialists, according to a notice posted on the website of law firm…

Advertisement

Comments are closed.